T

Targovax ASA

37 employees

Targovax develops active immunotherapy in the form of cancer vaccines for application in post-operation treatments.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

2010

Funding rounds raised

Total raised

$3.6M

from 2 investors over 2 rounds

T

Targovax ASA raised $939K on January 12, 2022

Investors: -

T

Targovax ASA raised $3.6M on June 6, 2013

Investors: Abodetek®

FAQ